Diabetes mellitus: Pathology review

1,381,450views

Diabetes mellitus: Pathology review

Watch later

Watch later

Sepsis
Infective endocarditis: Clinical
Endocarditis: Pathology review
Endocarditis
Fever of unknown origin: Clinical
Salmonella typhi (typhoid fever)
Plasmodium species (Malaria)
Schistosomes
Zinc deficiency and protein-energy malnutrition: Pathology review
Hypophosphatemia
Hyponatremia
Hyponatremia: Clinical
Hypertriglyceridemia
Hypertensive disorders of pregnancy: Clinical
Preeclampsia & eclampsia
Gestational hypertension
Gestational diabetes
Contraception: Clinical
Preterm labor
Erectile dysfunction
PDE5 inhibitors
Fallopian tube and uterus histology
Endometriosis
Chlamydia trachomatis
Neisseria gonorrhoeae
Treponema pallidum (Syphilis)
Congenital syphilis
Sexually transmitted infections: Clinical
HIV (AIDS)
Herpes simplex virus
Human papillomavirus
Endometrial hyperplasia
Endometrial cancer
Endometrial hyperplasia and cancer: Clinical
Ovarian cysts and tumors: Pathology review
Cervical cancer
Cervical cancer: Clinical
Cervical cancer: Pathology review
Ectopic pregnancy
Endometritis
Pelvic inflammatory disease
Ovarian germ cell tumors
Ovarian cysts, cancer, and other adnexal masses: Clinical
Sexual dysfunctions: Clinical
Anatomy clinical correlates: Wrist and hand
Placenta previa
Placental abruption
Vaginal versus cesarean delivery: Clinical
Antepartum hemorrhage: Clinical
Postpartum hemorrhage
Postpartum hemorrhage: Clinical
Urinary incontinence
Stages of labor
Shock
Shock: Clinical
Shock: Pathology review
Opioid agonists, mixed agonist-antagonists and partial agonists
Opioid use disorder
Opioid antagonists
Syncope: Clinical
Hypertension: Clinical
Hypertension
Hypertension: Pathology review
Local anesthetics
Ventricular arrhythmias: Pathology review
Supraventricular arrhythmias: Pathology review
Wolff-Parkinson-White syndrome
Ventricular fibrillation
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Atrial fibrillation
Atrial flutter
Ventricular tachycardia
Premature ventricular contraction
Heart failure
Heart failure: Pathology review
Heart failure: Clinical
Nephrotic syndromes: Pathology review
Nephritic and nephrotic syndromes: Clinical
Nephritic syndromes: Pathology review
Frank-Starling relationship
Aortic dissection
Aortic dissections and aneurysms: Pathology review
Aortic aneurysms and dissections: Clinical
Pericarditis and pericardial effusion
Atherosclerosis and arteriosclerosis: Pathology review
Angina pectoris
Leg ulcers: Clinical
Chronic venous insufficiency
Ischemic stroke
Stroke: Clinical
ECG cardiac hypertrophy and enlargement
Hypertrophic cardiomyopathy
Cardiomyopathies: Pathology review
Cardiomyopathies: Clinical
Dilated cardiomyopathy
Restrictive cardiomyopathy
Long QT syndrome and Torsade de pointes
Brugada syndrome
Action potentials in pacemaker cells
Asthma
Asthma: Clinical
Pneumonia
Pneumonia: Clinical
Pneumonia: Pathology review
Streptococcus pneumoniae
Pneumocystis jirovecii (Pneumocystis pneumonia)
Reading a chest X-ray
Mycobacterium tuberculosis (Tuberculosis)
Tuberculosis: Pathology review
Upper respiratory tract infection
General anesthetics
Lung cancer
Lung cancer: Clinical
Lung cancer and mesothelioma: Pathology review
Chronic obstructive pulmonary disease (COPD): Clinical
Sleep apnea
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Sleep disorders: Clinical
Sleep
Narcolepsy (NORD)
Clinical Skills: BiPAP and CPAP
Restrictive lung diseases
Restrictive lung diseases: Pathology review
Diffuse parenchymal lung disease: Clinical
Idiopathic pulmonary fibrosis
Hypersensitivity pneumonitis
Sarcoidosis
Acetaminophen (Paracetamol)
Paracetamol toxicity
Non-steroidal anti-inflammatory drugs
Respiratory alkalosis
Metabolic and respiratory alkalosis: Clinical
Metabolic and respiratory acidosis: Clinical
Advanced cardiac life support (ACLS): Clinical
Respiratory acidosis
Pancoast tumor
Congenital cytomegalovirus (NORD)
Congenital TORCH infections: Pathology review
Alport syndrome
Pediatric ear, nose, and throat conditions: Clinical
Turner syndrome
Down syndrome (Trisomy 21)
Developmental milestones: Clinical
Neonatal sepsis
Auditory transduction and pathways
Muscular dystrophy
Cerebral palsy
Respiratory syncytial virus
Respiratory distress syndrome: Pathology review
Newborn management: Clinical
Neonatal respiratory distress syndrome
Appendicitis
Appendicitis: Clinical
Appendicitis: Pathology review
Meckel diverticulum
Neonatal jaundice: Clinical
Hirschsprung disease
Congenital gastrointestinal disorders: Pathology review
Pediatric allergies: Clinical
Pediatric constipation: Clinical
Pediatric vomiting: Clinical
Febrile seizure
Rotator cuff tear
Carpal tunnel syndrome
Achilles tendon rupture
Patellar tendon rupture
Anterior cruciate ligament injury
Spinal disc herniation
Sciatica
Degenerative disc disease
Compartment syndrome
Osteomyelitis
Bone tumors
Osteoporosis
Osteomalacia and rickets
Osteoarthritis
Rheumatoid arthritis
Gout
Psoriatic arthritis
Ankylosing spondylitis
Septic arthritis
Bursitis
Polymyositis
Dermatomyositis
Myasthenia gravis
Lambert-Eaton myasthenic syndrome
Sjogren syndrome
Systemic lupus erythematosus
Raynaud phenomenon
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Role of Vitamin K in coagulation
Clot retraction and fibrinolysis
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Sensitivity and specificity
Positive and negative predictive value
Sickle cell disease (NORD)
Sickle cell disease: Clinical
Cystic fibrosis
Cystic fibrosis: Pathology review
Cystic fibrosis: Clinical
Phenylketonuria (NORD)
Non-corticosteroid immunosuppressants and immunotherapies
Glucocorticoids
Child abuse: Clinical
Abdominal hernias
Hernias: Clinical
Inguinal hernia
Femoral hernia
Volvulus
Varicocele
Nutcracker syndrome
Testicular tumors: Pathology review
Testicular torsion
Intestinal atresia
Tracheoesophageal fistula
Necrotizing enterocolitis
Diabetes mellitus
Diabetes mellitus: Clinical
Diabetes mellitus: Pathology review
Gestational diabetes
Hypoglycemics: Insulin secretagogues
Insulins
Diabetic nephropathy
Diabetic retinopathy
Diabetes insipidus
Insulin
Diabetes insipidus and SIADH: Pathology review
Pituitary gland histology
Anatomy of the thyroid and parathyroid glands
Thyroid and parathyroid gland histology
Pituitary tumors: Pathology review
Pituitary adenomas and pituitary hyperfunction: Clinical
Pituitary adenoma
Hyperprolactinemia
Prolactinoma
Cushing syndrome
Cushing syndrome: Clinical
Cushing syndrome and Cushing disease: Pathology review
Acromegaly
Gigantism
Hypopituitarism
Hypopituitarism: Clinical
Hypopituitarism: Pathology review
Hyperpituitarism
Pituitary apoplexy
Adrenal gland histology
Primary adrenal insufficiency
Adrenal insufficiency: Clinical
Adrenal insufficiency: Pathology review
Thyroid nodules and thyroid cancer: Clinical
Thyroid nodules and thyroid cancer: Pathology review
Thyroid cancer
Hashimoto thyroiditis
Thyroid storm
Thyroid hormones
Hypothyroidism and thyroiditis: Clinical
Hyperthyroidism
Hyperthyroidism: Pathology review
Hyperthyroidism: Clinical
Hyperthyroidism medications
Hypothyroidism
Hypothyroidism medications
Hypothyroidism: Pathology review
Toxic multinodular goiter
Graves disease
Cortisol
Renin-angiotensin-aldosterone system
Conn syndrome
Waterhouse-Friderichsen syndrome
Adrenal masses and tumors: Clinical
Adrenal masses: Pathology review
Skin cancer
Skin cancer: Pathology review
Skin cancer: Clinical
Sarcoptes scabiei (Scabies)
Anti-mite and louse medications
Psoriasis
Psoriatic arthritis
Eczematous rashes: Clinical
Atopic dermatitis
Contact dermatitis
Seborrhoeic dermatitis
Keratitis
Miscellaneous antifungal medications
Azoles

Transcript

Watch video only

In the Emergency Department, two individuals came in. One of them is 12-year-old Timmy, who is severely dehydrated, presents with rapid and deep breaths, abdominal pain, nausea and vomiting. On the clinical examination, his breath actually smells fruity and sweet. Timmy’s parents said that he had been eating a lot lately, but he actually lost weight. Also, they said that Timmy is also drinking water all the time and going to the bathroom a lot. The other person is 55-year-old Oliver, who also came in with severe dehydration, lethargy; and his family said he had a seizure about 2 hours ago, and in the past month, he had lost some weight, although he had been eating. Both individuals underwent several investigations, including glucose levels, ketones, BMP, and an ABG. Okay, based on both individuals’ symptoms, we can assume that both suffer from diabetes mellitus.

Diabetes mellitus is a condition where glucose can’t be properly moved from the blood into the cells. This leads to high levels of glucose in the blood and not enough of it inside cells. Since cells need glucose as a source of energy, not letting glucose enter means that the cells starve for energy despite having glucose right on their doorstep.

In general, the body controls how much glucose is in the blood with two hormones: insulin and glucagon. Both of these hormones are produced in the islets of Langerhans of the pancreas. Insulin is secreted by the beta cells, while glucagon is secreted by the alpha cells.

Insulin reduces blood glucose levels. It does that by binding to insulin receptors embedded in the cell membrane of insulin-responsive tissues, like muscle cells and adipose tissue. When activated, the insulin receptors cause vesicles containing glucose transporter that are inside the cell to fuse with the cell membrane, allowing glucose to be transported into the cell.

Okay, now, there are two types of diabetes mellitus, Type 1 and Type 2, and the main difference between them is the underlying mechanism that causes the blood glucose levels to rise.

Let’s start with Type 1 diabetes mellitus, which is an autoimmune condition. See, autoimmune conditions sometimes happen together. So on the exam, the past medical history might include a history of autoimmune thyroid disease like Hashimoto’s thyroiditis or vitiligo or lupus.

In type 1 diabetes, the immune system targets and destroys the beta-cells of the pancreas. A common target is an enzyme inside beta cells called glutamic acid decarboxylase, which helps make gamma aminobutyric acid or GABA, which, among others, increases insulin release and also has a protective and regenerative effect on the beta-cells. The high yield fact to remember is that the antibodies against glutamic acid decarboxylase are called GAD antibodies.

In addition, other antibodies like anti-islet cell antibodies can also be present. Without the protective and regenerative effect of GABA, the beta cells progressively decrease. Losing beta cells means less insulin, and less insulin means that glucose builds up in the blood, because it can’t enter the body’s cells.

Now, there is a gene complex involved in the regulation of the immune response, and this is called the human leukocyte antigen system, or HLA system. These genes code for the major histocompatibility complex, or MHC, which is a protein that’s extremely important in helping the immune system recognize foreign molecules, as well as maintaining self-tolerance. MHC is like the serving platter where antigens are presented to the immune cells. Interestingly, people with type 1 diabetes often have specific HLA genes in common; HLA-DR3 and HLA-DR4, both of which are high yield for your exams.

In diabetes mellitus type 1, destruction of beta cells usually starts early in life and individuals present with symptoms of diabetes before the age of 30. In type 1 diabetes, the tissues are very sensitive to insulin, but since there are less beta-cells, insulin levels are low. On histology, there is usually an islet leukocytic infiltrate.

There are four clinical symptoms of uncontrolled diabetes; there’s polyphagia, glucosuria, polyuria, and polydipsia. Let’s go through them one by one. Even though there’s a lot of glucose in the blood, it can’t get into cells, which leaves cells starved for energy, so in response, adipose tissue starts breaking down fat, called lipolysis, and muscle tissue starts breaking down proteins, called proteolysis both of which results in weight loss for someone with uncontrolled diabetes. This catabolism leads to polyphagia.

Now with high glucose levels, when blood gets filtered through the kidneys, some of it starts to spill into the urine, and this is called glycosuria. Since glucose is osmotically active, water tends to follow it, resulting in an increase in urination, or polyuria. Finally, because there is so much urination, people with uncontrolled diabetes become dehydrated, resulting in polydipsia.

Now, let’s move on to Type 2 diabetes mellitus. In type 2 diabetes, the body makes insulin, but the tissues don’t respond as well to it. The exact reason why cells don’t “respond” isn’t fully understood; essentially the body’s providing the normal amount of insulin, but the cells don’t move their glucose transporters to the membrane. This is called insulin resistance.

The most important risk factor for insulin resistance is obesity. Apart from this, there are also some genetic factors involved. We see this when we look at twin studies as well, where having a twin with type 2 diabetes increases the risk of developing type 2 diabetes, completely independent of other environmental risk factors.

In Type 2 diabetes, since tissues don’t respond as well to normal levels of insulin, the body ends up producing more insulin in order to get the same effect and move glucose out of the blood. This works for a while, and by keeping insulin levels higher than normal, blood glucose levels can be kept normal. This beta cell compensation, though, isn’t sustainable, and over time these overworked beta cells get exhausted, and eventually die off. When this happens, insulin levels will start decreasing. So, remember that the serum levels of insulin in type 2 diabetes are variable, depending on when it’s diagnosed.

Now, along with insulin, beta cells also secrete islet amyloid polypeptide, so while beta cells are cranking out insulin they also secrete an increased amount of amyloid polypeptide. Over time, amyloid polypeptide builds up and aggregates in the islets, so on histology, there will be amyloid polypeptide deposits in the pancreas along with a variable number of beta-cells, depending on when it’s diagnosed.

Now, type 2 diabetes usually appears after the age of 40 and presents similarly to type 1 diabetes with polydipsia, polyuria, polyphagia and sometimes weight loss.

Diagnosing type 1 or type 2 diabetes is done by getting a sense of how much glucose is floating around in the blood. Very commonly, a fasting glucose test is taken where the person doesn’t eat or drink, except water, that’s okay, for 8 hours and has their blood tested for glucose levels. A Level of 126 milligrams per deciliter or higher indicates diabetes. A non-fasting or random glucose test can be done at any time, with 200 milligrams per deciliter or higher being diagnostic for diabetes if the individual has symptoms. Another test is called an oral glucose tolerance test, where a person is given glucose, and then blood samples are taken at time intervals to figure out how well it’s being cleared from the blood. A glucose level over 200 milligrams per deciliter after 2 hours indicates diabetes.

Okay, so when blood glucose levels get high, the glucose can also stick to proteins that are floating around in the blood or in cells. So that brings us to the HbA1c test, which tests for the proportion of hemoglobin in red blood cells that have glucose stuck to it, or glycated hemoglobin. HbA1c level of 6.5% or higher indicates diabetes. This proportion of glycated hemoglobin doesn’t change day to day, so a high yield fact is that this test gives a sense for whether the blood glucose levels have been high over the past 3 months, which is the lifespan of a typical red blood cell.

Regarding treatment, in type 1 diabetes, insulin is always necessary because of decreased endogenous production. While in type 2 diabetes, lifestyle modifications like exercise and dietary changes are first line. In addition, other medications like metformin, SGLT2 inhibitors, and GLP-1 receptor agonists are the first-line pharmacologic intervention in type 2 diabetes, with insulin being an option if other medications fail to control glucose levels. It’s also important to treat and prevent complications in diabetes. For example, ACE inhibitors and ARBs have been shown to decrease the risk of diabetic nephropathy in individuals with diabetes and hypertension. In addition, yearly eye exams, urine microalbumin testing, and foot exams should be done.

Now, let’s go over one very high yield acute complication of diabetes that usually happens with type 1 diabetes, and it’s called diabetic ketoacidosis, or DKA. This usually happens when individuals aren’t rigorous with their insulin therapy or when the body is really stressed and needs more insulin, like during an infection.

To understand it, let’s go back to the process of lipolysis, where fat is broken down into free fatty acids. After that happens, the liver turns the fatty acids into ketone bodies, like aceto-acetic acid and beta hydroxybutyric acid. These ketones are important because they can be used by cells for energy, but they also increase the acidity of the blood, which is why it’s called ketoacidosis, which is a type of metabolic acidosis. This doesn’t typically happen in type 2 diabetes because there’s usually some level of endogenous insulin that prevents lipolysis.

Clinically, individuals with DKA are dehydrated, because a lot of glucose is lost through urine and they can develop Kussmaul respiration, which is a deep and rapid breathing as the body tries to move carbon dioxide out of the blood in an effort to reduce its acidity. Their breath also smells sweet and fruity because ketones break down into acetone, which escapes as a gas during exhalation.

Abdominal pain, nausea, vomiting, and, in severe DKA, mental status changes like obtundation and coma can occur.

Complications of DKA include acute cerebral edema, which is when there’s too much fluid in the intra- or extracellular space. In the case of DKA, there’s too much fluid in the extracellular space of the brain because glucose basically drags water out of cells. Other complications include cardiac arrhythmias, due to potassium imbalance, which can lead to sudden cardiac death. Finally, since people with DKA have poorly controlled diabetes, their immune system is also likely to be compromised. This means they are more vulnerable to common infections like candida, but also some that only affect people with immune deficiencies. One of these is mucormycosis; a life-threatening fungal infection caused by Rhizopus species that starts in the sinuses but can spread to the brain.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Type 1 Diabetes Mellitus in Pediatrics" Pediatrics in Review (2008)
  4. "Hyperglycemic Crises in Adult Patients With Diabetes" Diabetes Care (2009)
  5. "Diabetes mellitus: definition, classification and diagnosis" Wien Klin Wochenschr (2016)